Literature DB >> 6946244

U.S. centralized cancer patient data system for uniform communication among cancer centers.

P Feigl, N E Breslow, J Laszlo, R L Priore, W F Taylor.   

Abstract

The evolution of the Centralized Cancer Patient Data System, a cooperative venture of the 21 comprehensive cancer centers in the United States, and its structure at the end of 3 years of data collection are described. Functions of the data system are detailed in terms of input and output. It is concluded that the short-run objective of establishing a data system to provide high-quality patient data that ae 21 comprehensive cancer centers in the United States, and its structure at the end of 3 years of data collection are described. Functions of the data system are detailed in terms of input and output. It is concluded that the short-run objective of establishing a data system to provide high-quality patient data that ae 21 comprehensive cancer centers in the United States, and its structure at the end of 3 years of data collection are described. Functions of the data system are detailed in terms of input and output. It is concluded that the short-run objective of establishing a data system to provide high-quality patient data that are comparable among cancer centers has been largely accomplished. Moreover, the very process of setting up the national data system has benefited the participating centers by upgrading their individual cancer registries. For the future, the goal is to realize the research potential of this new cooperative data collection mechanism, as well as the accumulating data themselves. Progress toward the long-term goal is just beginning.

Entities:  

Mesh:

Year:  1981        PMID: 6946244

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  2 in total

Review 1.  Clinical research databases--a historical review.

Authors:  M F Collen
Journal:  J Med Syst       Date:  1990-12       Impact factor: 4.460

2.  Intelligent Medical Record--entry (IMR-E).

Authors:  D Trace; F Naeymi-Rad; D Haines; J J Robert; F deSouza Almeida; L Carmony; M Evans
Journal:  J Med Syst       Date:  1993-08       Impact factor: 4.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.